MKI67 and pancreatic neoplasm: Pancreatic cancers have rare mutations in pRb16,61 while pRb is frequently phosphorylated by CDKs in ki67-positive PDAC cells which indicates that this tumour suppressor is functionally inactivated in proliferating pancreatic cancer cells62.